Three-Statement Breakdown
REVENUE UP
Revenue rose 5.7% year over year to $34.1B, and carried a 14.4% net margin.
REVENUE
+5.7%
34,128
GROSS PROFIT
—
—
NET INCOME
+4.8%
4,902
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31,457 | 31,797 | 31,889 | 32,292 | 32,862 | 33,172 | 33,734 | 34,128 | +1.2% | +5.7% | |
| SG&A | (2,107) | (2,147) | (2,186) | (2,077) | (2,071) | (1,979) | (1,967) | (2,009) | +2.1% | -3.3% | |
| Operating income | 5,612 | 5,325 | 5,687 | 5,866 | 5,995 | 6,065 | 6,023 | 5,946 | -1.3% | +1.4% | |
| Interest expense | (372) | (382) | (399) | (420) | (427) | (441) | (449) | (461) | +2.7% | +9.8% | |
| Income tax | (1,284) | (1,182) | (1,177) | (1,174) | (1,158) | (1,059) | (1,023) | (961) | -6.1% | -18.1% | |
| Net income | 4,428 | 4,147 | 4,546 | 4,679 | 4,917 | 5,233 | 5,059 | 4,902 | -3.1% | +4.8% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-28 ↗